Portfolio company
MFX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops automated microfluidic bioreactor platforms and data generation infrastructure for researchers and manufacturers in the cell and gene therapy sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Stämm Biotech
This company develops automated microfluidic bioreactors for continuous production of biologics and cell therapies for pharmaceutical, biotechnology and cultivated meat organisations.
Stämm
This company develops automated microfluidic bioprocessors for continuous biomanufacturing to assist biotechnology, pharmaceutical and food-tech firms with biologics and cell therapy production.
Ori Biotech
This company develops automated manufacturing platforms for cell and gene therapy developers to scale production of advanced medicines.
Scinus Group
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
CellFE
The company develops microfluidic platforms for intracellular delivery of molecules to support cell therapy developers and researchers in manufacturing engineered cells.
Unicorn Bio
This company develops automated cell culture systems and bioreactors for researchers and manufacturers in the therapeutics and cultivated meat industries.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
